title: High dose therapy for light chain amyloidosis: can we reduce treatment related mortality further?
authors.affiliation: Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece. mdimop@med.uoa.gr
authors.forename: Meletios
authors.initials: M
authors.lastname: Dimopoulos
authors.forename: Efstathios
authors.initials: E
authors.lastname: Kastritis
mesh_terms: D000686:Amyloidosis / Q000401:mortality / Q000628:therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods* / Q000401:mortality; D006801:Humans; D007147:Immunoglobulin Light Chains; D018579:Patient Selection; D015996:Survival Rate; D014182:Transplantation, Autologous
chemical_list: D000970:Antineoplastic Agents; D007147:Immunoglobulin Light Chains